Ignite Creation Date:
2024-05-05 @ 11:38 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00092482
Status:
COMPLETED
Last Update Posted:
2017-03-22
First Post:
2004-09-22
Brief Title:
Immunogenicity Bridge Between an Investigational Monovalent Vaccine and the Equivalent Component of Gardasil V501 a Quadrivalent Vaccine V501-012COMPLETED
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Genital Warts |
| Cervical Cancer |
Keywords: